Hi Forrest, I would say that 1 in 6 is greater than the 15% progression rates. This would imply that the company is painting a very positive picture for the future of TB testing using IGRAs and in particular QFT. And I would tend to agree that this acceptance by the key stakeholders will be the key driver to increased product sales and a tipping point. It will be at this point that product sales will start to accelerate as QFT is accepted as the new Latent TB diagnostic Gold Standard.
Hi Forrest,
ReplyDeleteI would say that 1 in 6 is greater than the 15% progression rates. This would imply that the company is painting a very positive picture for the future of TB testing using IGRAs and in particular QFT. And I would tend to agree that this acceptance by the key stakeholders will be the key driver to increased product sales and a tipping point. It will be at this point that product sales will start to accelerate as QFT is accepted as the new Latent TB diagnostic Gold Standard.
regards,
GT
Well done GT. 10/10. :)
ReplyDelete